Long-Term Outcomes in Elderly Patients After Deferral of Coronary Revascularization Guided by Fractional Flow Reserve.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 08 2022
Historique:
pubmed: 15 3 2022
medline: 27 8 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

Little evidence is available regarding the long-term outcome in elderly patients after deferral of revascularization based on fractional flow reserve (FFR).Methods and Results: From the J-CONFIRM registry (long-term outcomes of Japanese patients with deferral of coronary intervention based on fractional flow reserve in multicenter registry), 1,262 patients were divided into 2 groups according to age: elderly and younger patients (aged ≥75 or <75 years, respectively). The primary endpoint was the cumulative 5-year incidence of target vessel failure (TVF), defined as a composite of cardiac death, target vessel-related myocardial infarction (TVMI), and clinically driven target vessel revascularization (CDTVR). Cumulative 5-year incidence of TVF was not significantly different between elderly and younger patients (14.3% vs. 10.8%, P=0.12). Cardiac death occurred more frequently in elderly patients than younger patients (4.4% vs. 0.8%, P<0.001), whereas TVMI and CDTVR did not differ between groups (1.3% vs. 0.9%, P=0.80; 10.7% vs. 10.1%, P=0.80, respectively). FFR values in lesions with diameter stenosis <50% were significantly higher in elderly patients than in younger patients (0.88±0.07 vs. 0.85±0.07, P=0.01), whereas this relationship was not observed in those with diameter stenosis ≥50%. Elderly patients had no excess risk of ischemic events related to the deferred coronary lesions by FFR, although FFR values in mild coronary artery stenosis were modestly different between elderly and younger patients.

Sections du résumé

BACKGROUND
Little evidence is available regarding the long-term outcome in elderly patients after deferral of revascularization based on fractional flow reserve (FFR).Methods and Results: From the J-CONFIRM registry (long-term outcomes of Japanese patients with deferral of coronary intervention based on fractional flow reserve in multicenter registry), 1,262 patients were divided into 2 groups according to age: elderly and younger patients (aged ≥75 or <75 years, respectively). The primary endpoint was the cumulative 5-year incidence of target vessel failure (TVF), defined as a composite of cardiac death, target vessel-related myocardial infarction (TVMI), and clinically driven target vessel revascularization (CDTVR). Cumulative 5-year incidence of TVF was not significantly different between elderly and younger patients (14.3% vs. 10.8%, P=0.12). Cardiac death occurred more frequently in elderly patients than younger patients (4.4% vs. 0.8%, P<0.001), whereas TVMI and CDTVR did not differ between groups (1.3% vs. 0.9%, P=0.80; 10.7% vs. 10.1%, P=0.80, respectively). FFR values in lesions with diameter stenosis <50% were significantly higher in elderly patients than in younger patients (0.88±0.07 vs. 0.85±0.07, P=0.01), whereas this relationship was not observed in those with diameter stenosis ≥50%.
CONCLUSIONS
Elderly patients had no excess risk of ischemic events related to the deferred coronary lesions by FFR, although FFR values in mild coronary artery stenosis were modestly different between elderly and younger patients.

Identifiants

pubmed: 35283368
doi: 10.1253/circj.CJ-21-1024
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1329-1336

Commentaires et corrections

Type : CommentIn

Auteurs

Yasushi Ueki (Y)

Department of Cardiovascular Medicine, Shinshu University School of Medicine.

Shoichi Kuramitsu (S)

Department of Cardiology, Kokura Memorial Hospital.

Tatsuya Saigusa (T)

Department of Cardiovascular Medicine, Shinshu University School of Medicine.

Keisuke Senda (K)

Department of Cardiovascular Medicine, Shinshu University School of Medicine.

Hitoshi Matsuo (H)

Department of Cardiovascular Medicine, Gifu Heart Center.

Kazunori Horie (K)

Department of Cardiovascular Medicine, Sendai Kousei Hospital.

Hiroaki Takashima (H)

Department of Cardiology, Aichi Medical University.

Hidenobu Terai (H)

Department of Cardiology, Kanazawa Cardiovascular Hospital.

Yuetsu Kikuta (Y)

Department of Cardiology, Fukuyama Cardiovascular Hospital.

Takayuki Ishihara (T)

Kansai Rosai Hospital Cardiovascular Center.

Tomohiro Sakamoto (T)

Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center.

Nobuhiro Suematsu (N)

Department of Cardiology, Saiseikai Fukuoka General Hospital.

Yasutsugu Shiono (Y)

Department of Cardiovascular Medicine, Wakayama Medical University.

Taku Asano (T)

Department of Cardiology, St. Luke's International Hospital.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University.

Katsuhiko Masamura (K)

Department of Cardiology, Nakamura Hospital.

Tatsuki Doijiri (T)

Department of Cardiology, Yamato Seiwa Hospital.

Yohei Sasaki (Y)

Department of Cardiology, Chidoribashi Hospital.

Manabu Ogita (M)

Department of Cardiology, Juntendo University Shizuoka Hospital.

Tairo Kurita (T)

Department of Cardiology and Nephrology, Mie University Graduate School of Medicine.

Akiko Matsuo (A)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital.

Ken Harada (K)

Department of Cardiology, Chubu Rosai Hospital.

Kenji Yaginuma (K)

Department of Cardiology, Juntendo University Urayasu Hospital.

Noriyoshi Kanemura (N)

Department of Cardiology, Kainan Hospital.

Shinjo Sonoda (S)

Department of Cardiovascular Failure Therapy, Saga University.

Hiroyoshi Yokoi (H)

Department of Cardiology, Fukuoka Sanno Hospital.

Nobuhiro Tanaka (N)

Department of Cardiology, Tokyo Medical University Hachioji Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH